A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures The primary objective is to evaluate the efficacy of 2 doses of perampanel (8 and 12 mg) in comparison to placebo given as an adjunctive therapy in subjects with refractory partial seizures.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune